PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1984 | 1 |
| 2002 | 3 |
| 2003 | 4 |
| 2004 | 6 |
| 2005 | 22 |
| 2006 | 13 |
| 2007 | 27 |
| 2008 | 231 |
| 2009 | 386 |
| 2010 | 322 |
| 2011 | 280 |
| 2012 | 282 |
| 2013 | 238 |
| 2014 | 310 |
| 2015 | 301 |
| 2016 | 289 |
| 2017 | 252 |
| 2018 | 243 |
| 2019 | 295 |
| 2020 | 272 |
| 2021 | 266 |
| 2022 | 315 |
| 2023 | 276 |
| 2024 | 306 |
| 2025 | 200 |
| 2026 | 119 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"J Clin Oncol"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Five-Year Follow-Up of the Phase III ASCOT Trial of Adjuvant S-1 After Resection for Biliary Tract Cancer.
- Ikeda M, Nakachi K, Konishi M, Kajikawa R, Katayama H, Sano Y, Sugiura T, Satoi S, Murakawa M, Tomokuni A, Nara S, Takahashi Y, Okada KI, Hama N, Kamei K, Kamata K, Natsume S, Okusaka T, Furuse J, Ueno M.
- J Clin Oncol. 2026 Sep 23;44(30):2903-2907. doi: 10.1200/JCO-26-00017.
- PMCID: PMC13682723
Ikeda M, et al.J Clin Oncol. 2026.PMCID: PMC13682723 -
Erratum: Molecularly Guided Therapy Versus Continued Chemotherapy in Unfavorable Cancer of Unknown Primary: Updated Efficacy and Safety From the Randomized, Phase II CUPISCO Study.
- Krämer A, Bochtler T, Pauli C, Shiu KK, Cook N, Janoski de Menezes J, Pazo-Cid RA, Losa F, Robbrecht DGJ, Tomášek J, Arslan C, Özgüroğlu M, Arni P, Bigot F, Kim SY, Naito Y, Italiano A, Chalabi N, Durán-Pacheco G, Ma N, Scarato J, Ross JS, Moch H, Mileshkin L.
- J Clin Oncol. 2026 Sep 17;44(30):2980. doi: 10.1200/JCO-26-02285.
- PMCID: PMC13682721
Krämer A, et al.J Clin Oncol. 2026.PMCID: PMC13682721 -
Erratum: Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation.
- Al Malki MM, Bo-Subait S, Logan B, Olson J, Kou J, Smith S, Leckrone E, Wu J, Stefanski HE, Auletta JJ, Spellman SR, Malmberg C, Askar M, Cusatis R, Shaffer BC, Modi D, Khimani F, Gooptu M, Hamadani M, Madbouly A, Maiers M, Fingerson S, Cook R, Ballen K, Loren A, Larkin K, Arai S, Qayed M, Choi SW, Broglie L, Shaw BE, Devine SM, Jimenez Jimenez AM.
- J Clin Oncol. 2026 Sep 16;44(30):2979. doi: 10.1200/JCO-26-02255.
- PMCID: PMC13682719
Al Malki MM, et al.J Clin Oncol. 2026.PMCID: PMC13682719 -
Mindfulness and Tai Chi for Sleep, Fatigue, and Pain in Distressed People After Cancer Treatment: A Partially Randomized Patient-Preference Comparative Effectiveness Trial.
- Ma Y, Carlson LE, Jones JM, Lawal OA, Oberoi D, Piedalue KA, Santa Mina D, Speca M, Wayne PM.
- J Clin Oncol. 2026 Sep 16;44(30):2929-2940. doi: 10.1200/JCO-25-01967.
- PMCID: PMC13682724
Ma Y, et al.J Clin Oncol. 2026.PMCID: PMC13682724 -
Personalized Circulating Tumor DNA Analysis for Predicting Outcomes and Tracking Response to Radiotherapy and Pembrolizumab in Localized Sarcomas: Analysis of the SU2C-SARC032 Trial.
- Subramanian A, Nouth SCL, Nemat-Gorgani N, Soudi S, Ballman KV, Heise RS, Johns C, Sears TJ, Roohani S, Krcek R, Hong AM, Weinhold KJ, van de Rijn M, Brigman BE, Riedel RF, Mowery YM, Kirsch DG, Moding EJ.
- J Clin Oncol. 2026 Sep 9;44(30):2941-2952. doi: 10.1200/JCO-26-00769.
- PMCID: PMC13682727
Subramanian A, et al.J Clin Oncol. 2026.PMCID: PMC13682727 -
Molecularly Guided Therapy Versus Continued Chemotherapy in Unfavorable Cancer of Unknown Primary: Updated Efficacy and Safety From the Randomized, Phase II CUPISCO Study.
- Krämer A, Bochtler T, Pauli C, Shiu KK, Cook N, Janoski de Menezes J, Pazo-Cid RA, Losa F, Robbrecht DGJ, Tomášek J, Arslan C, Özgüroğlu M, Arni P, Bigot F, Kim SY, Naito Y, Italiano A, Chalabi N, Durán-Pacheco G, Ma N, Scarato J, Ross JS, Moch H, Mileshkin L.
- J Clin Oncol. 2026 Sep 3;44(30):2895-2902. doi: 10.1200/JCO-25-02974.
- PMCID: PMC13682720
Krämer A, et al.J Clin Oncol. 2026.PMCID: PMC13682720 -
Efficacy and Tolerability of Zenocutuzumab in Advanced NRG1 Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial.
- Cleary JM, Springfeld C, Arnold D, Hollebecque A, Gbolahan O, Nagasaka M, Siena S, Opdam F, Sunakawa Y, Cassier PA, Trikha G, Gort EH, Florou V, Greil R, La Porte PF, Gandhi PJ, Garner F, Wasserman E, Adeyemi S, Schram AM.
- J Clin Oncol. 2026 Jul 1;44(30):2908-2918. doi: 10.1200/JCO-25-03128.
- PMCID: PMC13682725
Cleary JM, et al.J Clin Oncol. 2026.PMCID: PMC13682725 -
Clinical and Psychological Outcomes After Monoclonal Gammopathy Screening: A Population-Based Screening Study and Subsequent Randomized Trial of Follow-Up.
- Rögnvaldsson S, Thorsteinsdóttir S, Eythorsson E, Wessman ID, Sigurdardottir GA, Vidarsson B, Onundarson PT, Agnarsson B, Sigurdardottir M, Olafsson I, Thorsteinsdottir I, Bjornsson AS, Oskarsson JT, Olafsson A, Gislason G, Sverrisdottir I, Long TE, Guðmundsdóttir ER, Thordardottir AR, Jonsson A, Palsson R, Indridason OS, Hultcrantz M, Durie BGM, Harding SJ, Aspelund T, Landgren O, Love TJ, Kristinsson SY.
- J Clin Oncol. 2026 Jul 14;44(29):2781-2786. doi: 10.1200/JCO-25-02771.
- PMCID: PMC13668039
Rögnvaldsson S, et al.J Clin Oncol. 2026.PMCID: PMC13668039 -
Randomized Trial of Hypofractionated Postmastectomy Radiation Therapy in Women With Breast Reconstruction (RT CHARM, Alliance A221505).
- Poppe MM, Le-Rademacher JJ, Haffty BG, Hansen EK, Agarwal JP, Wagner JL, Kong I, Armer JM, Arthur DW, Whelan TJ, Kour O, Lee MK, Ruddy KJ, Partridge AH, Carey LA, Lustberg M, Bernstein MB, Chow SL, Stecklein SR, Gaffney DK, Khan AJ.
- J Clin Oncol. Author manuscript. 2026 Oct 12:JCO2600474. doi: 10.1200/JCO-26-00474. Online ahead of print.
- PMCID: PMC13660432
Poppe MM, et al.J Clin Oncol. Author manuscript. 2026.PMCID: PMC13660432 -
NRG-BR002: A Randomized Phase II/III Trial of Metastasis-Directed Ablation With First-Line Systemic Therapy for Oligometastatic Breast Cancer.
- Chmura SJ, Winter KA, Woodward WA, Borges VF, Salama JK, Al-Hallaq HA, Matuszak MM, Milano MT, Jaskowiak NT, Jagsi R, Kuhn P, Lucci A, Meas S, Shishido SN, Mason J, Bazan JG Jr, Nordal RA, Lee DY, Smith BD, Gabos Z, Ye JC, Kahn ST, Vallow LA, Zoberi I, Razaq W, Mishra MV, Lupinacci KM, Moughan J, Mamounas EP, White JR.
- J Clin Oncol. Author manuscript. 2026 Oct 7:JCO2600201. doi: 10.1200/JCO-26-00201. Online ahead of print.
- PMCID: PMC13647293
Chmura SJ, et al.J Clin Oncol. Author manuscript. 2026.PMCID: PMC13647293